Table of Contents
CAR-T Cell Therapy in India: Eligibility, Process and Cost in 2026
By Dr. Gajendra Kumar Himanshu
CAR-T Cell Therapy in India is a highly advanced immunotherapy that involves the collection of a patient's own T cells, genetically modifying them to recognise cancer cells and infusion back into the body. In 2026, it is used largely for selected relapsed or refractory blood malignancies, including certain B-cell lymphomas and acute lymphoblastic leukaemias, following assessment by a specialist oncology team.
In this blog, we discuss who may be eligible for CAR-T cell therapy, how the treatment process works, probable side effects, expected hospital care and the factors that determine the final treatment cost.
The Importance of CAR-T Cell Therapy
Cancer treatment has come a long way in the previous 10 years. In addition to chemotherapy, radiation therapy, surgery, targeted therapy and immunotherapy, CAR-T cell therapy has become a personalised therapeutic option for some patients with recurrent or inadequately responsive blood cancer.
CAR-T therapy is essential because it takes advantage of the patient's immune system in a more specific way. CAR-T cells are engineered to identify and kill certain proteins on cancer cells, rather than depending on drugs that attack rapidly dividing cells. This method has yielded promising outcomes in some cases of relapsed or refractory B-cell malignancies.
India too has made strides in this space with the development of home-grown CAR-T products such as NexCAR19. This has resulted in better access to advanced cellular therapy for qualified patients in the country.
What Is CAR-T Cell Treatment?
"CAR-T" is short for Chimeric Antigen Receptor T-cell therapy. T cells are a type of white blood cell that have a crucial part in the body's immunological response.
In CAR-T therapy, doctors take T cells from a patient's blood. The cells are then altered in a lab so they can detect a particular target on cancer cells. After the changed cells are made, they are pumped back into the patient's bloodstream.
Once inside the body, the CAR-T cells can detect and attack cancer cells that have the target protein on them. That's why the therapy is sometimes referred to as a customised kind of cancer treatment.
Eligibility for CAR-T Cell Therapy in India
CAR-T cell treatment is not for all cancer patients. Eligibility is determined following a complete assessment by a haematologist, medical oncologist, transplant expert and other members of the cancer care team.
In India, CAR-T is normally reserved for certain patients with B-cell tumours, such as certain kinds of B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukaemia, especially in cases with relapsed or refractory disease.
What Factors Do Doctors Consider When Recommending CAR-T Therapy?
The doctor considers the patient's kind of cancer, prior therapies, response of the disease, general physical condition, organ function, infection risk, blood counts, and ability to withstand intensive monitoring.
The cancer cells also need to carry the right target, such as CD19 in some B-cell malignancies. The specific qualifying criteria may vary depending on the CAR-T product, the hospital's protocol and the patient's clinical status.
CAR-T Cell Therapy Procedure: One Step at a Time
The CAR-T process normally consists of many phases. It's not a one-day treatment, as the patient's cells need to be gathered, altered, processed and then given under tight medical supervision.
1. Medical Assessment and Testing
The oncology team does scans, blood tests, bone marrow testing if needed and other assessments to see if CAR-T cell therapy may be appropriate before starting treatment.
2. T-Cell Harvest
The first step involves removing the patient's T cells from the blood via a method called leukapheresis. In this operation, blood is taken from the patient, the cells needed are sorted out, and the remaining blood components are returned to the body.
3. Laboratory T-Cell Engineering
The gathered T cells are transported to a specialist production site. Here they are genetically engineered to produce CAR-T cells that can find and kill cancer cells.
4. Chemotherapy for Conditioning
Patients may be given lymphodepleting chemotherapy, a short-term chemotherapy, before receiving the CAR-T cell infusion. This prepares the body for the infused CAR-T cells.
5. CAR-T Cell Infusion and Monitoring
The CAR-T cells are put into the patient through a vein. After the infusion, the patient should be closely monitored, as some adverse effects can appear during the days or weeks after the treatment.
Potential Side Effects of CAR-T Cell Therapy
CAR-T therapy can be very beneficial for certain individuals, but it can also induce major negative effects. Treatment should therefore be given in a centre with experience of CAR-T-related problems.
Adverse Effect | What It Means | Typical Symptoms |
|---|---|---|
Cytokine Release Syndrome (CRS) | Immune response that happens when CAR-T cells are very active and release inflammatory chemicals into the circulation. | Fever, low blood pressure, trouble breathing, tiredness, fast heart rate |
Immune Effector Cell-Associated Encephalopathy Syndrome (ICANS) | Possible neurological side effects affecting the brain and nerve system after CAR-T therapy. | Confusion, headache, tremors, difficulty speaking, drowsiness, seizures (rare) |
Risk of Infection | It can temporarily weaken the immune system and raise the risk for infections. | Chills, fever, frequent infections |
Low Blood Cell Count | CAR-T treatment can temporarily lower the level of healthy blood cells. | Fatigue, easy bruising, bleeding, increased risk of infection |
General Side Effects | Patients may encounter transient treatment-related symptoms while they recover. | Weakness, nausea, extended recovery time |
Our oncology team regularly monitors patients throughout treatment and provides supportive care, as needed, to help manage these side effects.
CAR-T Cell Therapy Cost in India 2026
The cost of CAR-T cell therapy in India can vary greatly based on the type of CAR-T product utilised, the facility, manufacturing charges, pre-treatment evaluation, chemotherapy, hospital admission, critical care needs, supportive drugs and follow-up care.
In many cases, the overall cost in 2026 might be in the region of around ₹40 lakh to ₹60 lakh; however, the actual amount can vary greatly depending on the hospital and the patient. The CAR-T product alone can represent a significant portion of the whole cost of therapy.
Patients and families should ask for a detailed estimate of the total costs, which includes the cell manufacture, hospital stay, drugs, laboratory examinations, care of problems and follow-up consultations.
What Questions Should Patients Ask Before Starting CAR-T Therapy?
Before deciding on CAR-T cell therapy, it is useful to ask the treating team whether the patient's eligibility criteria are met. What target will the CAR-T cells recognise? How long may the treatment process last? What side effects can be expected? Will hospital admission be required?
Patients should also inquire about follow-up treatment, infection control, support for caregivers, financial counselling, and the availability of emergency management if difficulties develop after infusion.
If you want to read more about cancer treatment, then you can visit the official website of the National Cancer Institute.
Consult Today
If you or someone you know has lymphoma, acute lymphoblastic leukaemia, or another blood cancer that has not responded as expected to traditional treatment, a careful discussion with an expert oncology team can help determine whether CAR-T cell therapy may be appropriate.
At Oncare Cancer Hospital, the oncologists will first analyse each patient's diagnosis, treatment history, overall health, and care needs before suggesting a treatment plan customised to them. Call today to find out about treatment choices and what's next in your cancer care journey.
Disclaimer
This material is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis or treatment. CAR-T cell therapy is not suitable for every patient, and treatment decisions should only be made following a full assessment by a certified oncologist or haematology specialist. Please visit your own healthcare provider for personal advice about your diagnosis and treatment choices.
Frequently Asked Questions
CAR-T cell therapy in India is largely used to treat specific relapsed or refractory blood malignancies, including certain B-cell lymphomas and B-cell acute lymphoblastic leukaemia. Eligibility depends on your diagnosis, treatment history, the type of cancer you have and your general health.
The process can take several weeks, while the patient's T cells are collected, altered in a laboratory and readied for infusion. The actual timescale will depend on the treatment centre, the manufacturing method and the medical state of the patient.
The overall cost can vary greatly, but typical treatment packages can range from about ₹40 lakh to ₹60 lakh, inclusive of cell production, hospital stay, chemotherapy, monitoring, drugs and supportive care.
CAR-T therapy provides a potentially meaningful treatment option for some individuals but may also induce major adverse effects including cytokine release syndrome, neurologic problems, risk of infection and low blood counts. It should be administered under close monitoring by an expert oncology team.
Written and Verified by:
Dr. Gajendra Kumar Himanshu Exp: 10 Yr
Medical Officer
Book an Appointment
Related Blogs
Cancer Staging Explained: What the TNM System Really Means
Stage refers to how much cancer has grown or spread in the body. The TNM system is the most extensively used staging system and lets doctors assess the size of the original tumour (T), if the lymph nodes are involved (N), and if the cancer has spread to distant organs (M).
Neoadjuvant Therapy: Why Some Patients Get Chemo Before Surgery
Neoadjuvant therapy is a type of cancer treatment that is given before surgery to shrink a tumour, make surgery more successful, and lower the possibility that cancer may spread. It can involve chemotherapy, targeted therapy, immunotherapy, hormone therapy or radiation, all of which assist doctors in developing a more effective treatment strategy.
Palliative Care vs Hospice: Understanding the Difference
Both palliative care and hospice care emphasise comfort, symptom management, and quality of life, but they are not the same. Palliative care can start at any point in a serious disease, and can be given together with therapies like chemotherapy or radiation therapy. Hospice care is primarily for persons who are nearing the end of life and whose primary objective has changed from treating the disease to giving comfort and support.